EUVIMEDEUVIMED entdecken
Crossref

L26/O-170 Impact of pre-transfer serum progesterone fluctuation on implantation in single euploid Hormonal-Replacement-Therapy Frozen Embryo Transfer (HRT-FET) cycles

S. Samir, H. Didar, B. Lawrenz, R. Del Gallego, S. Selim, H. Fatemi

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Samir und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does pre-transfer serum progesterone (P4) fluctuation influence implantation in single euploid Hormonal-Replacement-Therapy Frozen Embryo Transfer (HRT-FET) cycles? Summary answer Pre-transfer progesterone fluctuations were not associated with implantation in single euploid HRT-FET cycles. What is known already Adequate progesterone exposure is essential for endometrial receptivity in FET cycles, particularly in HRT cycles lacking endogenous luteal support. Low serum P4 levels near to the embryo transfer have been associated with reduced implantation and live birth rates, prompting routine monitoring and rescue strategies. However, most studies assess serum P4 at a single time point, typically on transfer day, which does not capture short-term hormonal fluctuations. P4 levels may fluctuate due to differences in absorption, metabolism, and administration timing of the last dose, even with identical protocols. The clinical significance of these fluctuations remains unclear. Study design, size, duration This retrospective cohort study included 231 single euploid HRT-FET cycles with serum P4 measured one day before the embryo transfer (ET − 1) and on ET day, between January 2023 and December 2025, with definitive implantation outcomes. Participants/materials, setting, methods Patients started oral Estradiol-Valerate on cycle-day 2/3. Endometrial preparation was monitored (ultrasound/hormonal assessment). When a triple-lining endometrium was achieved, exogenous P4 was initiated (day0). Embryo transfer was performed 5 days later. P4 fluctuation was defined as the absolute change in serum P4 (|ΔP4|), assessed as both a median-split and continuous variable. Implantation was defined as serum β-hCG levels (≥15mIU/mL). Multivariable logistic regression adjusted for age at transfer, BMI, and embryo quality. Main results and the role of chance A total of 231 euploid HRT-FET cycles with definitive implantation outcome were included. The median P4 fluctuation between ET-1 and ET-day (|ΔP4|) was 3.63 ng/mL, defining low (≤3.63; n = 116) and high (>3.63; n = 115) fluctuation groups. Baseline age, BMI, and embryo quality were comparable between groups (all p > 0.25). P4 levels differed as expected, with higher P4 on ET-day in the high-fluctuation group (11.33 vs 17.32 ng/mL, p < 0.001) and higher |ΔP4| (1.54 vs 8.65 ng/mL, p < 0.001). Implantation occurred in 71.6% of low-fluctuation cycles and 67.0% of high-fluctuation cycles. In adjusted logistic regression (age, BMI, embryo quality), high fluctuation was not associated with implantation (aOR 0.78, 95% CI 0.44–1.38, p = 0.395). When analyzed continuously, |ΔP4| was also not associated with implantation (aOR 1.006 per 1 ng/mL, p = 0.758). Limitations, reasons for caution The retrospective design limits causal inference. The relatively small sample size may limit power to detect subtle effects. Differences in luteal phase support regimens, along with variability in P4 administration and blood sampling timings, may have influenced measured serum P4 levels and fluctuation estimates. Wider implications of the findings Short time progesterone fluctuations before embryo transfer were not linked to implantation in euploid HRT-FET cycles. Future analyses including ongoing pregnancy will further clarify clinical relevance. Standardized monitoring protocols and larger prospective studies are required before fluctuation-based clinical decision-making can be recommended. Trial registration number No

Zitieren

APA

Samir, S., Didar, H., Lawrenz, B., Gallego, R. D., Selim, S., & Fatemi, H. (2026). L26/O-170 Impact of pre-transfer serum progesterone fluctuation on implantation in single euploid Hormonal-Replacement-Therapy Frozen Embryo Transfer (HRT-FET) cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.168

Vancouver

Samir S, Didar H, Lawrenz B, Gallego RD, Selim S, Fatemi H. L26/O-170 Impact of pre-transfer serum progesterone fluctuation on implantation in single euploid Hormonal-Replacement-Therapy Frozen Embryo Transfer (HRT-FET) cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.168

BibTeX
@article{Samir2026,
  author = {Samir, S. and Didar, H. and Lawrenz, B. and Gallego, R. Del and Selim, S. and Fatemi, H.},
  title = {L26/O-170 Impact of pre-transfer serum progesterone fluctuation on implantation in single euploid Hormonal-Replacement-Therapy Frozen Embryo Transfer (HRT-FET) cycles},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.168}
}
Kostenlos starten →